The cardiovascular patient in dental practice: current clinical considerations

Carmen Lopez-Carriches, Cristina Meniz-García, Cristina Madrigal Martínez-Pereda, Isabel Leco-Berrocal

Abstract


Background:

Cardiovascular diseases are increasingly prevalent due to lifestyle factors and population aging. It is essential for dentists to be familiar with the most common cardiovascular conditions, the medications used to treat them, the risks associated with dental treatment, and the strategies to prevent medical emergencies.

Material and methods:

A bibliographic search was performed in PubMed/MEDLINE and the Cochrane Library, including articles published in English on cardiovascular patients in dentistry.

Results and discussion:

Cardiovascular diseases encompass a wide range of conditions, from arterial hypertension to ischemic heart disease. Patients with these conditions should be managed on an individualized basis in the dental clinic in order to prevent complications and medical emergencies during dental treatment.

Conclusions:

A comprehensive medical history is essential in cardiovascular patients, including a detailed review of their pharmacological treatment and potential drug interactions. Proper risk assessment, individualized treatment planning, and effective communication with the patient’s physician when necessary are key to preventing complications and medical emergencies during dental care. Continuous updating of cardiovascular knowledge is therefore fundamental in daily dental practice.

 

Received 21 March 2025

Accepted 15 April 2026

Published 20 May 2026


Keywords


Cardiovascular diseases; dental treatment; hypertension; ischemic heart disease; oral surgery; valvular heart diseases.

Full Text:

PDF

References


Bergler-Klein J. What’s new in the ESC 2018 guidelines for arterial hypertension. Wiener Klinische Wochenschrift. 2019;131(7):180–5.

Gupta K, Kumar S, Anand Kukkamalla M, Taneja V, Syed GA, Pullishery F, et al. Dental Management Considerations for Patients with Cardiovascular Disease—A Narrative Review. Reviews in Cardiovascular Medicine. 2022 Jul 20;23(8):261.

Anna G, Tomasz S, Marcin J, Katarzyna ST. Clinical assessment of the safe use local anaesthesia with vasoconstrictor agents in cardiovascular compromised patients: A systematic review. Medical Science Monitor. 2014;20:393–8.

Abu-Mostafa N, Aldawssary A, Assari A, Alnujaidy S, Almutlaq A. A prospective randomized clinical trial compared the effect of various types of local anesthetics cartridges on hypertensive patients during dental extraction. Journal of Clinical and Experimental Dentistry. 2015 Feb 1;7(1):e84-88.

James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014 Feb 5;311(5):507–20.

Thomopoulos C, Bazoukis G, Tsioufis C, Mancia G. Beta-blockers in hypertension: overview and meta-analysis of randomized outcome trials. Journal of Hypertension. 2020 Jul 7;38(9):1669–81.

Cutrell S, Alhomoud IS, Mehta A, Talasaz AH, Van BW, Dixon DL. ACE-Inhibitors in Hypertension: A Historical Perspective and Current Insights. springer link. 2023 Jun 7;25(9).

Zhu J, Chen N, Zhou M, Guo J, Zhu C, Zhou J, et al. Calcium channel blockers versus other classes of drugs for hypertension. Cochrane Database of Systematic Reviews. 2021 Oct 17;2021(10).

Mansbart F, Kienberger G, Sönnichsen A, Mann E. Efficacy and safety of adrenergic alpha-1 receptor antagonists in older adults: a systematic review and meta-analysis supporting the development of recommendations to reduce potentially inappropriate prescribing. BMC Geriatrics. 2022 Sep 28;22(1).

Sica DA, Gehr TWB. Direct Vasodilators and their Role in Hypertension Management: Minoxidil. The Journal of Clinical Hypertension. 2001 Mar;3(2):110–4.

Munger MA. Use of Angiotensin Receptor Blockers In Cardiovascular Protection: Current Evidence and Future Directions. Pharmacy and Therapeutics. 2011;36(1):22.

Villa A, Wolff A, Aframian D, Vissink A, Ekström J, Proctor G, et al. World Workshop on Oral Medicine VI: a systematic review of medication-induced salivary gland dysfunction: prevalence, diagnosis, and treatment. Clinical Oral Investigations. 2015 May 22;19(7):1563–80.

Kataoka M, Kido J, Shinohara Y, Nagata T. Drug-Induced Gingival Overgrowth—a Review. Biological and Pharmaceutical Bulletin. 2005;28(10):1817–21.

Mainas G, Santamaria P, Zoheir N, Alamri MM, Hughes F, Lu EMC, et al. Association between calcium-channel blockers and gingival enlargement: A case-control study. Journal of dentistry. 2024 Oct;149:105315.

Gopal S, Joseph R, Santhosh V, Kumar VH, Joseph S, Shete A. Prevalence of gingival overgrowth induced by antihypertensive drugs: A hospital-based study. Journal of Indian Society of Periodontology. 2015;19(3):308.

Balakumar P, Kavitha M, Nanditha S. Cardiovascular drugs-induced oral toxicities: A murky area to be revisited and illuminated. Pharmacological Research. 2015 Dec 1;102:81–9.

Kamath V, Setlur K, Yerlagudda K. Oral lichenoid lesions - A review and update. Indian Journal of Dermatology. 2015;60(1):102.

Dongari-Bagtzoglou A, Research, Science and Therapy Committee, American Academy of Periodontology. Drug-associated gingival enlargement. Journal of Periodontology. 2004 Oct;75(10):1424–31.

Villa A, Wolff A, Narayana N, Dawes C, Aframian D, Lynge Pedersen A, et al. World Workshop on Oral Medicine VI: a systematic review of medication-induced salivary gland dysfunction. Oral Diseases. 2016 Jan 20;22(5):365–82.

Becker DE. Cardiovascular Drugs: Implications for Dental Practice Part 1 — Cardiotonics, Diuretics, and Vasodilators. Anesthesia Progress. 2007 Dec;54(4):178–86.

Wright AJ, Gomes T, Mamdani MM, Horn JR, Juurlink DN. The risk of hypotension following co-prescription of macrolide antibiotics and calcium-channel blockers. Canadian Medical Association Journal. 2011 Jan 17;183(3):303–7.

Neuvonen P, Niemi M, Backman J. Drug interactions with lipid-lowering drugs: Mechanisms and clinical relevance. Clinical Pharmacology & Therapeutics. 2006 Dec;80(6):565–81.

Little JW, Miller CS, Henry RG, McIntosh BA. Antithrombotic agents: Implications in dentistry. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology. 2002 Jun 25;93(5):544–51.

Curtis J, Henderson DP, Zarghami M, Rashedi S, Behnood Bikdeli. Management of Antithrombotic Therapy in Patients Undergoing Dental Procedures. Journal of Thrombosis and Haemostasis. 2024 Oct 1;23(1):47–72.

Inchingolo F, Inchingolo AM, Piras F, Ferrante L, Mancini A, Palermo A, et al. Management of Patients Receiving Anticoagulation Therapy in Dental Practice: A Systematic Review. Healthcare. 2024 Aug 2;12(15):1537–7.

Napeñas JJ, Hong CHL, Brennan MT, Furney SL, Fox PC, Lockhart PB. The Frequency of Bleeding Complications After Invasive Dental Treatment in Patients Receiving Single and Dual Antiplatelet Therapy. The Journal of the American Dental Association. 2009 Jun;140(6):690–5.

Kämmerer PW, Frerich B, Liese J, Schiegnitz E, Al-Nawas B. Oral surgery during therapy with anticoagulants—a systematic review. Clinical Oral Investigations. 2014 Nov 22;19(2):171–80.

Breik O, Cheng A, Sambrook P, Goss A. Protocol in managing oral surgical patients taking dabigatran. Australian Dental Journal. 2014 Jul 30;59(3):296–301.

Hanken H, Gröbe A, Heiland M, Smeets R, Kluwe L, Wikner J, et al. Postoperative bleeding risk for oral surgery under continued rivaroxaban anticoagulant therapy. Clinical Oral Investigations. 2015 Oct 26;20(6):1279–82.

Lopez-Galindo M, Bagan J. Apixaban and oral implications. Journal of Clinical and Experimental Dentistry. 2015;7(4):e528–34.

Curto A, Curto D, Sanchez J. Managing patients taking edoxaban in dentistry. Journal of Clinical and Experimental Dentistry. 2017;9(2).

Izzetti R, Cinquini C, Nisi M, Mattiozzi M, Marotta M, Barone A. Direct Oral Anticoagulants and Bleeding Management Following Tooth Extractions—A Prospective Cohort Study. Dentistry Journal. 2024 Aug 30;12(9):279–9.

Lupi SM, Rodriguez y Baena A. Patients Taking Direct Oral Anticoagulants (DOAC) Undergoing Oral Surgery: A Review of the Literature and a Proposal of a Peri-Operative Management Protocol. Healthcare. 2020 Aug 20;8(3):281.

Boccatonda A, Frisone A, Lorusso F, Bugea C, Carmine MD, Schiavone C, et al. Perioperative Management of Antithrombotic Therapy in Patients Who Undergo Dental Procedures: A Systematic Review of the Literature and Network Meta-Analysis. International Journal of Environmental Research and Public Health. 2023 Mar 28;20(7):5293–3.

Engelen ET, Schutgens RE, Mauser-Bunschoten EP, van Es RJ, van Galen KP. Antifibrinolytic therapy for preventing oral bleeding in people on anticoagulants undergoing oral or dental procedures. Cochrane Database of Systematic Reviews. 2016 Aug 2;7(7).

Elad S, Zadik Y, Kaufman E, Leker R, Finfter O, Findler M. A new management approach for dental treatment after a cerebrovascular event: a comparative retrospective study. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics. 2010 Aug 1;110(2):145–50.

Lyons M, Smith C, Boaden E, Brady MC, Brocklehurst P, Dickinson H, et al. Oral care after stroke: Where are we now? European Stroke Journal. 2018 May 8;3(4):347–54.

Sanz M, Marco del Castillo A, Jepsen S, Gonzalez‐Juanatey JR, D’Aiuto F, Bouchard P, et al. Periodontitis and cardiovascular diseases: Consensus report. Journal of Clinical Periodontology. 2020 Feb 3;47(3):268–88.

Kreiner M, Okeson JP, Michelis V, Lujambio M, Isberg A. Craniofacial pain as the sole symptom of cardiac ischemia. The Journal of the American Dental Association. 2007 Jan;138(1):74–9.

Boon M, van Dorp E, Broens S, Overdyk F. Combining opioids and benzodiazepines: effects on mortality and severe adverse respiratory events. Annals of Palliative Medicine. 2020 Mar;9(2):542–57.

Silvestre FJ, Miralles-Jorda L, Tamarit C, Gascon R. Dental management of the patient with ischemic heart disease: an update. Medicina Oral: Organo Oficial De La Sociedad Espanola De Medicina Oral Y De La Academia Iberoamericana De Patologia Y Medicina Bucal. 2002 May 1;7(3):222–30.

Silvestre-Donat FJ. Dental management of ischaemic heart disease. Medicina oral : organo oficial de la Sociedad Espanola de Medicina Oral y de la Academia Iberoamericana de Patologia y Medicina Bucal. 2003;8(3):230.

Javed F, Khan J, Youssef M, Divakar DD, Michelogiannakis D. Dental management of patients with congestive heart failure before and after implantation of ventricular assist devices: linking the missing protocol. Scandinavian Cardiovascular Journal. 2020 Mar 18;54(4):206–11.

Imazio M. The 2023 new European guidelines on infective endocarditis: main novelties and implications for clinical practice. Journal of Cardiovascular Medicine. 2024 Jun 25;25(10):718–26.

Tsolka P. Dental Procedures in Patients with Atrial Fibrillation and New Oral Anticoagulants. Arrhythmia & Electrophysiology Review. 2014;3(2):85.

Rhodus NL, Little JW. Dental management of the patient with cardiac arrhythmias: an update. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology. 2003 Dec;96(6):659–68.

Chaudhry S, Jaiswal R, Sachdeva S. Dental considerations in cardiovascular patients: A practical perspective. Indian Heart Journal. 2016 Jul;68(4):572–5.




DOI: https://dx.doi.org/10.21622/AMPDR.2026.06.1.2025

Refbacks

  • There are currently no refbacks.


Copyright (c) 2026 Carmen LOPEZ-CARRICHES, Cristina MENIZ-GARCÍA, Cristina MADRIGALMARTÍNEZ-PEREDA, Isabel LECO-BERROCAL

Advances in Medical, Pharmaceutical and Dental Research

E-ISSN: 2812-4898

P-ISSN: 2812-488X

 

Published by:

Academy Publishing Center (APC)

Arab Academy for Science, Technology and Maritime Transport (AASTMT)

Alexandria, Egypt

ampdr@aast.edu